Veraxa Biotech
$0.030000
3
-$0.00-3.23%Thursday 20:00
+$0.00+0.33%Thursday 20:00After hours
Statistics
Day High
0.0301
Day Low
0.0301
52W High
0.0301
52W Low
0.03
Volume
3,104
Avg. Volume
-
Mkt Cap
4.24M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
Show More
CEO
Christoph Antz
Employees
8
Country
Switzerland
ISIN
CH1478199107
Listings
0 Comments
Share your thoughts
FAQs
What is Veraxa Biotech stock price today?▼
The current price of VRXAW is $0.03 USD — it has decreased by -3.23% in the past 24 hours. Watch Veraxa Biotech stock price performance more closely on the chart.
What is Veraxa Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Veraxa Biotech stocks are traded under the ticker VRXAW.
What is Veraxa Biotech market cap?▼
Today Veraxa Biotech has the market capitalization of 4.24M
How many employees does Veraxa Biotech have?▼
As of November 1, 2026, the company has 8 employees.
In which sector is Veraxa Biotech located?▼
Veraxa Biotech operates in the Health & Wellness sector.
When did Veraxa Biotech complete a stock split?▼
Veraxa Biotech has not had any recent stock splits.
Where is Veraxa Biotech headquartered?▼
Veraxa Biotech is headquartered in Heidelberg, Switzerland.